The race for a coronavirus vaccine continues with Pfizer Inc. (NYSE: PFE) taking the spotlight once more.
People keeping up with the race already know Pfizer was one of the nine companies in September that took a stance to “stand with science” and not rush a vaccine that hasn’t been properly vetted.
The Food and Drug Administration is insisting on companies having at least two months of data on half of the people participating in the trial after their final dose before approving the Emergency Use Authorization.
Pfizer announced Friday it won’t apply its vaccine for emergency authorization until after the election — despite President Donald Trump insisting it would have a cure before the elections.
However, of the four companies currently in the late-stage testing phase of their vaccines, Pfizer’s aggressive timeline goals are beating Moderna Inc. (Nasdaq: MRNA), AstraZeneva Plc. (Nasdaq: AZN) and Johnson & Johnson (NYSE: JNJ).
With so many eyes on this company the past few months, the stock market has begun to take notice… and so have I.
You see, after taking a look at the charts I noticed a major coronavirus vaccine play being made with the pay-off potential of $7.2 million… in the next 38 days…
P.S. Chances are, you’re missing out on the No. 1 easiest way to profit from stocks in 2020.
Have you heard of the rise of Robinhood? The “no fee” investment app…
The one where you could’ve made 556% in six days on Hertz.
Wall Street wasn’t paying attention to any of these names… they missed out. Now everyone wants to know… where will the “Robinhood Effect” strike next?
Well, we can tell you…